Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,372 signal articles · 92 in last 24h · 115,903 total before filter · latest 24m ago
92last 24h
1739last 7d
290● bullish (7d)
164● bearish (7d)
205publishers
AllMacro313Earnings812M&A101Regulatory25Product15Analyst24
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
US stocks open higher, spotlight on Fed
Reuters60d agoneutral
US stocks open higher, spotlight on Fed

June 17 (Reuters) - The main U.S. stock indexes opened higher on Wednesday, as chip stocks rebounded ahead of the first interest rate decision under new Federal Reserve Chair Kevin Warsh.

Treasury Yields Rise Ahead of First Fed Decision Under Warsh
Barrons.com60d agoneutral
Treasury Yields Rise Ahead of First Fed Decision Under Warsh

Treasury yields tick higher ahead of the first interest rate decision under Fed Chairman Kevin Warsh. Rates are expected to remain unchanged. Investors are curious about how Warsh will change the central bank's communications with the public and its forward guidance.

Micron Stock Rebounds But Memory-Chip Frenzy Faces a Fed Test
Barrons.com61d agoneutral
Micron Stock Rebounds But Memory-Chip Frenzy Faces a Fed Test

Micron Technology stock was back on the rise early Wednesday as the memory-chip maker looks to resume its relentless rally. Micron was leading the rebound in premarket trading, rising 3.5%, the second-best performer in the Only Intel was climbing more ahead of the open. When there’s nothing happening Micron stock tends to gain.

Big pharma taps UK playbook to pressure Europe on drug prices
Reuters Videos61d agoneutralVIDEO
Big pharma taps UK playbook to pressure Europe on drug prices

<body><p>STORY: Big pharma is receiving pushback from European capitals on drug pricing.&nbsp;</p><p>So they’re turning to a playbook that brought them success in the UK.</p><p>Making threats to pull investment plans to pressure policymakers.&nbsp;</p><p>The industry notched a win when the British government agreed to increase medicine spending as part of a broader deal to avoid U.S.-imposed tariffs.&nbsp;</p><p>The latest nation to face pressure is Germany, which has been debating legislation to tighten spending on medicines.&nbsp;</p><p>A Reuters European Pharma correspondent Maggie Fick said pressure in the last week has ramped up.&nbsp;</p><p>"The CEO of Pfizer wrote a letter to the German chancellor warning that their future investments in the country may be at risk over these proposed changes to pricing laws."</p><p>Meanwhile, AstraZeneca warned that it may not launch new medicines in Germany if these changes go ahead.</p><p>Earlier in June, Eli Lilly announced it would halve a planned $2.7 billion investment, also citing the proposed legislation.&nbsp;</p><p>This bid to cap costs has centered Germany in a broader tussle between drugmakers and European governments that began several months ago.</p><p>That tension has been sharpened by the impact on Europe of U.S. President Donald Trump's pricing push.</p><p>This aims to tie prescription medicine prices in the lucrative U.S. market to ​lower prices elsewhere, including in Europe.</p><p>Major drugmakers have struck deals with the White House to lower drug costs in exchange for tariff exemptions, adding to pressure for increasing prices elsewhere.</p></body>

WeRide and Uber Target Zurich Robotaxi Launch as European Expansion Accelerates
InvestorsHub61d agoneutral
WeRide and Uber Target Zurich Robotaxi Launch as European Expansion Accelerates

WeRide (NASDAQ:WRD) and Uber Technologies (NYSE:UBER) plan to introduce commercial robotaxi services in the Greater Zurich Region later this year, extending their autonomous mobility partnership in Europe following a recent deployment announcement in Madrid. The service is expected to launch during 2026, pending approval from Switzerland’s Federal Roads Office (FEDRO).

Investing.com61d agoneutral
Trump supports Canada’s Chinese EV import cap arrangement, Carney says

Investing.com -- President Donald Trump expressed approval of Canada's agreement with China that limits Chinese electric vehicle imports through a quota system with reduced tariffs, Canadian Prime Minister Mark Carney said Wednesday at the Group of Seven leaders summit in Evian, France.

Nasdaq Futures Rising as Iran Peace Deal Boosts the Market Ahead of Fed Decision
Barrons.com61d agoneutral
Nasdaq Futures Rising as Iran Peace Deal Boosts the Market Ahead of Fed Decision

Stocks were on track to rise Wednesday after more details about the U.S.-Iran peace deal leaked, bolstering hopes that the two countries are on the brink of reaching an agreement to end the war in the Middle East. Futures tracking the tech-heavy Nasdaq 100 gained 0.5%, while S&P 500 futures added 0.1%. The market looked set for a broader rally on Wednesday after The Wall Street Journal reported that the U.S. would allow Iran to immediately begin selling oil and fuel under the deal to end the war, citing people familiar with the agreement.

Bloomberg61d agoneutral
ECB Officials Say Peace in Iran Isn’t Enough to Fix Energy Shock

(Bloomberg) -- European Central Bank officials are signaling that a US-Iran peace accord won’t necessarily stop them lifting interest rates further, even if it prevents a more pronounced overshoot in inflation.Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranIran’s Deputy Foreign Minister Confirms Deal Reached With USNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealStudios in Microsoft’s Xbox Division B

Nike gets World Cup opportunity it can’t afford to waste
TheStreet61d agoneutral
Nike gets World Cup opportunity it can’t afford to waste

Nike (NKE) is entering the World Cup with one of the biggest marketing opportunities in sports. The brand has new football boots, new federation shirts, a global campaign, and thousands of revamped store displays tailored around sport’s biggest stage. That should be a great situation for a brand ...

Review & Preview: Warsh Watch
Barrons.com61d agoneutral
Review & Preview: Warsh Watch

The Dow rose 332 points, or 0.6%, to finish at a record high. Despite the downward slide of oil prices, trading ahead of Wednesday’s Fed interest rate decision was relatively “light and featureless,” writes Joe Mazzola, head trading and derivatives strategist at Charles Schwab. Kevin Warsh’s first press conference as Fed chairman is the big event tomorrow (more on that below), but the U.S. Census is also set to release a significant economic barometer on Wednesday morning: May retail sales.